The Problem
Following Omnicell’s acquisition of InPharmics in April 2017, the organization needed to rapidly commercialize the DSCSA Management Module to capitalize on an urgent market opportunity. With a critical November 2017 federal regulatory deadline approaching—requiring manufacturers to provide electronic transaction records and implement 2D barcodes—hospital pharmacies across the country desperately needed compliance solutions. However, without comprehensive training materials, Omnicell risked losing market share to competitors and failing to generate expected revenue from the newly acquired 150-hospital customer base. Leadership required a strategic assessment to determine the optimal training approach, identify implementation risks, and establish a clear development roadmap that would enable successful product launch while meeting the compressed regulatory timeline.
Description
I led a comprehensive needs analysis to evaluate training requirements for Omnicell’s newly acquired DSCSA Management Module, a critical compliance tool for hospital pharmacies navigating complex federal drug supply chain regulations. This strategic assessment directly supported revenue generation by enabling the commercialization of the InPharmics acquisition.
The analysis addressed multiple stakeholder needs across product management, marketing, and customer success teams. I conducted stakeholder interviews with subject matter experts, evaluated existing training resources, and assessed the technical learning requirements for Directors of Pharmacy (DOPs) who would be primary users of the module.
Key deliverables included:
Strategic Recommendations: Developed a multi-modal training strategy featuring Adobe Captivate simulations and online modules, optimizing for both customer accessibility and scalability across 150+ hospitals.
Risk Assessment: Identified critical project risks including staffing constraints, release timeline pressures, and technical dependencies. Proactively flagged the impact of instructional designer vacancy and interface branding updates on project delivery.
Resource Planning: Established development requirements, timelines (4-week delivery with 100-hour estimate), and cross-functional dependencies to ensure successful execution.
Stakeholder Alignment: Documented open questions regarding long-term customer support, workflow integration with InPharma services, and module access protocols to facilitate executive decision-making.
This needs analysis provided leadership with the data-driven insights necessary to make informed investment decisions and successfully launch DSCSA training ahead of the November 2017 regulatory deadline. The resulting training modules supported customer compliance and contributed to revenue generation from the InPharmics product line.